BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2011
View Archived Issues
GlaxoSmithKline reflects on achievements of third quarter 2011
Read More
In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor
Read More
Bristol-Myers Squibb offers report on third quarter 2011
Read More
Mibefradil dihydrochloride given with temozolomide in murine glioma model
Read More
Lilly initiates patient recruitment in phase III study of LY-2439821
Read More
Novartis obtains approval in Japan for new indication for Sandostatin LAR
Read More
Japanese authorities approve Beselna cream for actinic keratosis
Read More
Japanese researchers identify new biomarker for diagnosis/monitoring of RA
Read More
Angiogenesis inhibitor may enhance effects of therapy with oncolytic virus
Read More
Preclinical results reported for LEE-011 in human liposarcoma
Read More
Canadian and Chinese scientists disclose new flavonoid dimers
Read More
Novel compounds for diabetes prepared by Chinese team
Read More
biOasis enters agreement with Shire Human Genetic Therapies
Read More
Novel neuropeptide S receptor antagonists presented by U.S. team
Read More
Synairgen reports preclinical results of aerosolized IFN-beta use in viral pneumonia
Read More
Hanmi applies for E.U. orphan drug designation for LAPS-rhGH
Read More
New iron complexes for cancer disclosed by IHI Corporation
Read More
New nicotinic acetylcholine alpha7 receptor ligand prodrugs disclosed by Bristol-Myers Squibb
Read More
Bausch & Lomb completes patient recruitment in BOL-303259-X study
Read More
NIH discontinues use of tenofovir gel in HIV prevention study
Read More
European Commission approves Novartis' triple combination pill for high blood pressure
Read More
Japanese authorities expand approval of Pfizer's Diflucan
Read More
NICE recommends Eliquis for prevention of VTE in hip and knee surgery
Read More
Inspiration Biopharmaceuticals begins second pivotal study of OBI-1
Read More
Regeneron and Bayer commence Chinese phase III study of Eylea
Read More